Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
May 11 2021 - 8:29AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
Under the Securities Exchange Act of 1934
For the month of May 2021
Commission File Number 001-38716
GAMIDA CELL LTD.
(Translation of registrant’s name into
English)
5 Nahum Heftsadie Street
Givaat Shaul, Jerusalem 91340 Israel
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual
reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
On May 11, 2021, Gamida Cell Ltd. (the “Company”) issued
a press release, a copy of which is furnished as Exhibit 99.1 to this Form 6-K.
The information included under the captions “Omidubicel, a proprietary,
investigational advanced cell therapy for allogeneic bone marrow transplant,” “GDA-201, a proprietary innate NK cell immunotherapy,”
“Corporate Highlights,” “First Quarter 2021 Financial Results” and “Expected 2021-2022 Milestones and Key
Events” of the press release, as well as the Consolidated Statements of Financial Position, Comprehensive Loss and Cash Flows appearing
therein are hereby incorporated by reference into the Company’s Registration Statement on Form F-3 (File No. 333-234701), the Registration
Statement on Form F-3 (File No. 333-253720) and the Registration Statement on Form S-8 (File No. 333-238115).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
GAMIDA CELL LTD.
|
|
|
|
May 11, 2021
|
By:
|
/s/ Shai Lankry
|
|
|
Shai Lankry
|
|
|
Chief Financial Officer
|
2
Gamida Cell (NASDAQ:GMDA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Gamida Cell (NASDAQ:GMDA)
Historical Stock Chart
From Sep 2023 to Sep 2024